Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mengde Shi
Institution:
Third Affiliated Hospital of Harbin Medical University
Observed institutions:
Harbin Medical University,
Third Affiliated Hospital of Harbin Medical University
ORCID:
0009-0006-4344-4973
Observed ORCID:
0009-0006-4344-4973
OpenAlex ID:
A5113420618
USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
·
Cancer Immunology Research
·
21
Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer
2025
·
Bojun Wang
, Yingjue Li
, et al.
·
Cell Reports Medicine
·
10
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer
2024
·
Yuanyu Liao
, Rui Yang
, et al.
·
Oncogene
·
9
Tumor aggression-defense index–a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer
2025
·
Tong Wu
, Lin Fang
, et al.
·
Journal of Translational Medicine
·
8
PDF
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses
2025
·
Yuli Ruan
, Mengde Shi
, et al.
·
Cancer Biology and Medicine
·
2
PDF
Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
·
Cancer Immunology Research
·
1
Supplementary Fig. S2 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Data from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S1 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S4 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Tables from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S6 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S3 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S5 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Fig. S7 from Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma
2026
·
Yue Ma
, Mengde Shi
, et al.
Supplementary Figure 10 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 2 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 5 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 3 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 11 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 1 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Data from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Table 3 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 6 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Supplementary Figure 8 from USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment
2025
·
Shuling Han
, Luying Cui
, et al.
Show more works
View as search
Works count:
30
Citation count:
51
H-index:
4
I10-index:
2
Year
Topic
Type